Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Lixisenatide for type 2 diabetes mellitus
Mikkel Christensen
, Filip K Knop,
Tina Vilsbøll
, Jens Juul Holst
80
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lixisenatide for type 2 diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Lixisenatide
100%
A1 Receptor
50%
Receptor Agonist
50%
Glucagon-like
50%
Type 2 Diabetes Prevention
33%
Duration of Action
16%
Once-daily
16%
Metformin
16%
Clinical Development
16%
Monotherapy
16%
Drug Class
16%
Health Problems
16%
Clinical Evidence
16%
Long-acting Insulin
16%
Meeting Abstracts
16%
Once-daily Regimen
16%
Antidiabetic Treatment
16%
Chemical Properties
16%
Pharmacological Data
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Lixisenatide
100%
Glucagon Like Peptide 1 Receptor Agonist
50%
Disease
16%
Antidiabetic Agent
16%
Metformin
16%
Long Acting Insulin
16%
Monotherapy
16%